Efficacy of ERYSENG® PARVO/LEPTO on swine farms with leptospirosis problems

Strona główna Wiedza Efficacy of ERYSENG® PARVO/LEPTO on swine farms with leptospirosis problems

Efficacy of ERYSENG® PARVO/LEPTO on swine farms with leptospirosis problems

Leptospirosis is a cause of reproductive loss in breeding herds and has been reported in swine from all parts of the world. When it is first introduced into a susceptible breeding herd, or during periods of waning herd immunity, it can cause very appreciable losses through abortion, or the full-term birth of dead pigs, or weak pigs of reduced viability or infertility. ERYSENG® PARVO/LEPTO is a new octavalent combined parvovirus, erysipelas and leptospira vaccine adjuvanted with HIPRAMUNE® Gd. The objective of this study was to assess the efficacy of the ERYSENG® PARVO/LEPTO vaccine on swine farms with reproductive problems due to leptospirosis.

O tym artykule

Opublikowano w

IPVS Congress, 2016

Autorzy

Scherer, C.; Puig, A.; Camprodon, A.; Coll, M.; Cesio, M.; March, R.

Streszczenie

Vaccination with ERYSENG® PARVO LEPTO was shown to be efficacious against leptospira infections by a reduction in the percentage of abortions, a reduction in the number of stillborn and mummies per litter and a reduction in leptospira infections in the vaccinated animals.

Powiązane usługi

Powiązane produkty

Udostępnij na